New glioblastoma lab opens in Durham, offering hope for patients

A new glioblastoma research lab has opened in Durham, aiming to provide hope for patients suffering from this aggressive brain cancer. Glioblastoma is the most common and deadly type of brain cancer, with only a 5% five-year survival rate. The lab, launched by the Glioblastoma Foundation, is designed to reduce the high costs of genomic testing, which can range from $5,000 to over $25,000, and currently only 10% of patients have access to such testing. The facility will enable scientists to analyze DNA from tumor samples, utilizing advanced equipment, including ultrasound technology, to identify unique genetic mutations. This capability allows for the testing of up to 15 samples simultaneously, providing detailed molecular insights that can guide physicians in making informed treatment decisions. The goal is to tailor therapies to the specific genetic makeup of each tumor, potentially sparing patients from ineffective and harsh treatments like chemotherapy and radiation. Michele Haywood, who attended the lab's opening on behalf of her daughter diagnosed with glioma, expressed the importance of such testing for patients and their families. She emphasized the need for accessible testing options that could lead to better treatment alternatives with fewer side effects. The lab's commitment to ensuring that all patients, regardless of their financial situation, can access these vital services reflects a broader aim to improve outcomes for glioblastoma patients. The lab is expected to start accepting patient samples by early 2025, marking a significant step forward in glioblastoma research and patient care, with hopes of ultimately finding a cure for this challenging disease.